Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Research and Innovation Action · Running

FORTIFY Fortify - Framework for Optimized Regulation, Trade Secrets, and Intellectual Property in a Federated European Health Data Space

Coordinator
Karolinska Institutet, Sweden
Runs
1 May 2026 to 30 April 2029
Status
Running
EU funding
€6.0m
Total cost
€11.5m
Partners
64 organisations in 15 countries
Type
Research and Innovation Action
Grant agreement
101251225

What the project is doing

In the project's own words, from its summary on CORDIS.

The European Health Data Space (EHDS) promises to unlock unprecedented opportunities for data-driven healthcare innovation by enabling the secure reuse of health data across Europe. However, realizing this vision requires robust safeguards to build trust among all stakeholders, protect privacy, and preserve the rights of data holders. FORTIFY directly addresses this challenge by delivering a comprehensive FORTIFY Framework that seamlessly integrates legal, technical, and governance measures to safeguard innovation while promoting data access.

Key components of the FORTIFY Framework include clear legal, technical and governance guidelines to protect intellectual property rights, standardized template contracts for transparent and consistent data access agreements, digital data processing technologies for robust IP protection and traceability, and quantitative utility benchmarks for managing IP utility. The project actively engages a broad range of stakeholders—including health data holders, health data access bodies, health data users, patients, industry, and policymakers—in co-designing these solutions through an established Multistakeholder Forum, ensuring diverse needs are met and fostering a culture of trust, collaboration, and continuous feedback.

Validation of the FORTIFY Framework will be carried out through ten real-world use cases, simulating the EHDS user journey, workflows, and ensuring practical applicability and effectiveness across diverse data sharing settings.

Topics

Who is involved

OrganisationCityCountryRole
Karolinska InstitutetStockholmSwedenCoordinator
Resmed Pty LtdBella VistaAustraliaAssociatedpartner
Agence Des Donnees De (soins De) SanteBrusselsBelgiumParticipant
Bayer SA-NVDiegem (Machelen)BelgiumAssociatedpartner
Janssen Pharmaceutica NVBeerseBelgiumParticipant
Janssen-Cilag NVBeerseBelgiumAssociatedpartner
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Pfizer S.A./N.V.BelgiumBelgiumAssociatedpartner
TimelexBruxelles / BrusselBelgiumParticipant
Ucb BiopharmaBruxelles / BrusselBelgiumAssociatedpartner
Ucb BiopharmaBruxelles / BrusselBelgiumParticipant
Ucb Pharma SABruxelles / BrusselBelgiumAssociatedpartner
Vaccine Monitoring Collaboration for EuropeBruxelles / BrusselBelgiumParticipant
Sanofi Pasteur Limited CanadaTorontoCanadaAssociatedpartner
University of OttawaOttawaCanadaParticipant
Actelion Pharmaceuticals LtdAllschwilSwitzerlandAssociatedpartner
Ares Trading SACoinsinsSwitzerlandAssociatedpartner
Novartis Pharma AGBaselSwitzerlandParticipant
Abbvie Deutschland GmbH & Co KgWiesbadenGermanyAssociatedpartner
Bayer AktiengesellschaftLeverkusenGermanyParticipant
Boehringer Ingelheim InternationalgmbhIngelheimGermanyParticipant
Boehringer Ingelheim Pharma GmbH &co KgIngelheimGermanyAssociatedpartner
C.H. Boehringer Sohn AG & Co. KGIngelheim am RheinGermanyAssociatedpartner
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Janssen-Cilag GmbHNeussGermanyAssociatedpartner
Johnson & Johnson Medical GmbHNorderstedtGermanyAssociatedpartner
Merck Healthcare KgaaDarmstadtGermanyAssociatedpartner
Merck Kommanditgesellschaft Auf AktienDarmstadtGermanyParticipant
Patvocates GmbHRiemerlingGermanyParticipant
Sanofi-Aventis Deutschland GmbHFrankfurt Am MainGermanyAssociatedpartner
Novo Nordisk A/sBagsvaerdDenmarkParticipant
Agencia De Qualitat I Avaluacio Sanitaries De CatalunyaBarcelonaSpainParticipant
Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad ValencianaValenciaSpainParticipant
Teamit Research S.l.BarcelonaSpainParticipant
Universitat Politecnica De ValenciaValenciaSpainParticipant
Biomerieux SAMarcy-l'EtoileFranceParticipant
Janssen-CilagIssy Les MoulineauxFranceAssociatedpartner
Plateforme Des Donnees De SanteParisFranceParticipant
Sanofi Winthrop IndustrieGentillyFranceParticipant
Chinoin Private Co LtdBudapestHungaryAssociatedpartner
Merck Serono Ireland Ltd.DublinIrelandAssociatedpartner
Resmed Sensor Technologies LimitedDublinIrelandParticipant
Alma Mater Studiorum - Universita Di BolognaBolognaItalyParticipant
Irccs Azienda Ospedaliero- Universitaria Di BolognaBolognaItalyParticipant
Istituto Ortopedico RizzoliBolognaItalyParticipant
Janssen Vaccines & Prevention BVLeidenNetherlandsAssociatedpartner
Pfizer ABSollentunaSwedenAssociatedpartner
Astrazeneca UK LimitedCambridgeUnited KingdomParticipant
Clarivate Analytics (UK) LimitedLondonUnited KingdomParticipant
Glaxosmithkline Research & Development LimitedLondonUnited KingdomParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant
Janssen Cilag LimitedHigh WycombeUnited KingdomAssociatedpartner
Johnson & Johnson Medical LimitedEdinburghUnited KingdomAssociatedpartner
Msd R&d Innovation Centre LimitedLondonUnited KingdomAssociatedpartner
Pfizer LimitedSandwichUnited KingdomAssociatedpartner
Pfizer R&D UK LimitedSandwichUnited KingdomAssociatedpartner
Resmed Epn LtdDidcotUnited KingdomAssociatedpartner
Abbvie IncNorth Chicago IlUnited StatesParticipant
EMD Digital Inc.BurlingtonUnited StatesAssociatedpartner
Johnson & Johnson Services, Inc.New BrunswickUnited StatesAssociatedpartner

And 4 more organisations. Full list on CORDIS.

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI